These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17984124)

  • 1. Seroprevalence and risk factors for human papillomavirus in Taiwan.
    Wang IJ; Viscidi R; Hwang KC; Lin TY; Chen CJ; Huang LM; Chen HH; Chen CJ
    J Trop Pediatr; 2008 Feb; 54(1):14-8. PubMed ID: 17984124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
    Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
    J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
    Lu B; Hagensee ME; Lee JH; Wu Y; Stockwell HG; Nielson CM; Abrahamsen M; Papenfuss M; Harris RB; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):511-6. PubMed ID: 20086109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
    Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
    Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of human papillomavirus type 16 infection in the United States.
    Stone KM; Karem KL; Sternberg MR; McQuillan GM; Poon AD; Unger ER; Reeves WC
    J Infect Dis; 2002 Nov; 186(10):1396-402. PubMed ID: 12404154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of antibodies against E4 and E7 from human papillomavirus type 16 in Mexican soldiers.
    Plett-Torres T; Cruz-Valdez A; Esquivel-Guadarrama F; Hernández-Nevarez P; Lazcano-Ponce E; Gutiérrez-Xicotencatl L
    Arch Virol; 2007 Jan; 152(1):97-114. PubMed ID: 16896549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific HPV seroprevalence among young females in The Netherlands.
    Kramer M; Mollema L; Smits G; Boot H; de Melker H; van der Klis F
    Sex Transm Infect; 2010 Dec; 86(7):494-9. PubMed ID: 20519252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
    Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
    J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
    Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
    J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of human papillomavirus type 16 in children.
    Dunne EF; Karem KL; Sternberg MR; Stone KM; Unger ER; Reeves WC; Markowitz LE
    J Infect Dis; 2005 Jun; 191(11):1817-9. PubMed ID: 15871113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province].
    Rong S; Chen W; Wu L; Zhang X; Shen G; Liu Y; Zhao F; Ma J; Qiao Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):41-3. PubMed ID: 11955348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.
    David MP; Van Herck K; Hardt K; Tibaldi F; Dubin G; Descamps D; Van Damme P
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S1-6. PubMed ID: 19217149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.